These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The Prevalence and Management of Systemic Amyloidosis in Western Countries. Nienhuis HL; Bijzet J; Hazenberg BP Kidney Dis (Basel); 2016 Apr; 2(1):10-9. PubMed ID: 27536687 [TBL] [Abstract][Full Text] [Related]
26. The Pathology of Amyloidosis in Classification: A Review. Picken MM Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555 [TBL] [Abstract][Full Text] [Related]
27. Amyloid heart disease: a brief review of treatment options. Dubrey SW Postgrad Med J; 2012 Dec; 88(1046):700-5. PubMed ID: 22745180 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in the diagnosis and management of cardiac amyloidosis. Sher T; Gertz MA Future Cardiol; 2014 Jan; 10(1):131-46. PubMed ID: 24344669 [TBL] [Abstract][Full Text] [Related]
29. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]. Arbustini E; Gavazzi A; Merlini G Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807 [TBL] [Abstract][Full Text] [Related]
30. Cardiac Care of Patients with Cardiac Amyloidosis. Itzhaki Ben Zadok O; Kornowski R Acta Haematol; 2020; 143(4):343-351. PubMed ID: 32408301 [TBL] [Abstract][Full Text] [Related]
39. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience. Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248 [TBL] [Abstract][Full Text] [Related]
40. [Progress in the diagnosis and treatment of cardiac amyloidosis]. Jurczyszyn A; Engel A; Rajzer M; Czepiel J; Mazurs G Przegl Lek; 2014; 71(6):340-5. PubMed ID: 25344976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]